ES2133407T3 - Material de recubrimiento de heridas fabricado a base de fibras de colageno. - Google Patents

Material de recubrimiento de heridas fabricado a base de fibras de colageno.

Info

Publication number
ES2133407T3
ES2133407T3 ES93919123T ES93919123T ES2133407T3 ES 2133407 T3 ES2133407 T3 ES 2133407T3 ES 93919123 T ES93919123 T ES 93919123T ES 93919123 T ES93919123 T ES 93919123T ES 2133407 T3 ES2133407 T3 ES 2133407T3
Authority
ES
Spain
Prior art keywords
pct
collagen fibers
coating material
material made
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93919123T
Other languages
English (en)
Inventor
Franz Maser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Naturin GmbH and Co
Naturin Werk Becker and Co
Original Assignee
Naturin GmbH and Co
Naturin Werk Becker and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naturin GmbH and Co, Naturin Werk Becker and Co filed Critical Naturin GmbH and Co
Application granted granted Critical
Publication of ES2133407T3 publication Critical patent/ES2133407T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08HDERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
    • C08H1/00Macromolecular products derived from proteins
    • C08H1/06Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A61L15/325Collagen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/64Use of materials characterised by their function or physical properties specially adapted to be resorbable inside the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Materials For Medical Uses (AREA)
  • Laminated Bodies (AREA)
  • Gloves (AREA)

Abstract

SE DESCRIBE UN MATERIAL PARA CUBRIR HERIDAS, EN FORMA DE HOJA, BASADO EN FIBRAS DE COLAGENO, SUS LAMINACIONES Y UN PROCESO PARA PREPARARLO. EL MATERIAL PARA CUBRIR HERIDAS CONSISTE ESENCIALMENTE EN UN COLAGENO PARCIALMENTE MODIFICADO E INSOLUBLE, CARACTERIZADO POR LOS SIGUIENTES PARAMETROS: ENTRE 0,18 Y 0,40 MMOL/G DE NITROGENO AMIDICO; MENOS DE 5 MICROMOL/G DE GLUCOSAMINA Y MENOS DE 5 MICROMOL/G DE GALACTOSAMINA; TEMPERATURA DE CONTRACCION ENTRE 45 Y 60,0.
ES93919123T 1992-08-21 1993-08-20 Material de recubrimiento de heridas fabricado a base de fibras de colageno. Expired - Lifetime ES2133407T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4227681A DE4227681C2 (de) 1992-08-21 1992-08-21 Wundabdeckungsmaterial auf der Basis von Kollagenfasern und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ES2133407T3 true ES2133407T3 (es) 1999-09-16

Family

ID=6466040

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93919123T Expired - Lifetime ES2133407T3 (es) 1992-08-21 1993-08-20 Material de recubrimiento de heridas fabricado a base de fibras de colageno.

Country Status (7)

Country Link
US (2) US5520925A (es)
EP (1) EP0612252B1 (es)
JP (1) JPH07501004A (es)
AT (1) ATE179895T1 (es)
DE (2) DE4227681C2 (es)
ES (1) ES2133407T3 (es)
WO (1) WO1994004201A1 (es)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0668079B1 (de) * 1994-02-19 2003-04-23 Naturin GmbH & Co Wundabdeckungsmaterial auf Basis von Kollagenfasern in anatomisch angepasster Form
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
DE19504704B4 (de) 1995-02-13 2005-09-15 Naturin Gmbh & Co Eßbare Kollagenhülle, Verfahren zur Herstellung sowie die Verwendung derselben
DE29611414U1 (de) * 1996-06-29 1996-09-05 Kloo, Michael, 01847 Lohmen Isolierstoff für Verbände an Tieren
US6666892B2 (en) 1996-08-23 2003-12-23 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
EP1955721B1 (en) * 1996-08-23 2014-10-29 Cook Biotech, Inc. Collagen-based graft prosthesis
US8716227B2 (en) * 1996-08-23 2014-05-06 Cook Biotech Incorporated Graft prosthesis, materials and methods
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
US6066325A (en) * 1996-08-27 2000-05-23 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
US7435425B2 (en) 2001-07-17 2008-10-14 Baxter International, Inc. Dry hemostatic compositions and methods for their preparation
US8603511B2 (en) 1996-08-27 2013-12-10 Baxter International, Inc. Fragmented polymeric compositions and methods for their use
US20050208114A1 (en) * 1998-03-24 2005-09-22 Petito George D Composition and method for healing tissues
US7691829B2 (en) * 1998-03-24 2010-04-06 Petito George D Composition and method for healing tissues
US8882850B2 (en) * 1998-12-01 2014-11-11 Cook Biotech Incorporated Multi-formed collagenous biomaterial medical device
US6482240B1 (en) * 1999-12-07 2002-11-19 Ed. Geistlich Soehne Ag Fur Chemische Industrie Method of making a collagen membrane from porcine skin
US6309454B1 (en) 2000-05-12 2001-10-30 Johnson & Johnson Medical Limited Freeze-dried composite materials and processes for the production thereof
EP1305064B1 (en) 2000-07-28 2008-04-23 Anika Therapeutics Inc. Bioabsorbable composites of derivatized hyaluronic acid
US20030211793A1 (en) * 2001-03-05 2003-11-13 Eugene Bell Injectable bio-compatible material and methods of use
US7001988B2 (en) * 2001-09-25 2006-02-21 Keraplast Technologies, Ltd. Methods for controlling peptide solubility, chemically modified peptides, and stable solvent systems for producing same
US20040120910A1 (en) * 2002-04-10 2004-06-24 Dyke Mark Van Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
US7001987B2 (en) * 2002-04-22 2006-02-21 Keraplast Technologies, Ltd. Hydrogel with controllable mechanical, chemical, and biological properties and method for making same
US6914126B2 (en) * 2002-04-10 2005-07-05 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogenous crosslinked protein networks
US6989437B2 (en) * 2002-04-10 2006-01-24 Keraplast Technologies, Ltd. Methods for producing, films comprising, and methods for using heterogeneous crosslinked protein networks
US20040062793A1 (en) * 2002-07-05 2004-04-01 Dyke Mark Van Tissue defect dressings comprising proteinaceous networks
US7163321B2 (en) * 2002-07-25 2007-01-16 Steven Contarino Emergency vehicle grille
PL1484070T3 (pl) * 2003-06-05 2006-05-31 Baxter Int Kompozycje do naprawy i regeneracji ludzkiej opony twardej
US8834864B2 (en) * 2003-06-05 2014-09-16 Baxter International Inc. Methods for repairing and regenerating human dura mater
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
DE10355085A1 (de) * 2003-11-24 2005-06-23 Schure, Frank, Dr. Wundverband
EP1747033A1 (en) * 2004-04-30 2007-01-31 Burrell E. Clawson Apparatus and methods for isolating human body areas for localized cooling
JP4621563B2 (ja) * 2005-08-26 2011-01-26 新田ゼラチン株式会社 皮膚用保水シート
CN101454030B (zh) * 2006-05-31 2013-06-26 巴克斯特国际公司 用于脊柱外科手术中定向细胞向内生长和控制组织再生的方法
TWI436793B (zh) 2006-08-02 2014-05-11 Baxter Int 快速作用之乾密封膠及其使用和製造方法
US20080260794A1 (en) * 2007-02-12 2008-10-23 Lauritzen Nels J Collagen products and methods for producing collagen products
US9056151B2 (en) * 2007-02-12 2015-06-16 Warsaw Orthopedic, Inc. Methods for collagen processing and products using processed collagen
US8461409B2 (en) * 2007-03-14 2013-06-11 Canica Design Inc. Viscera protector
DE102007040370B4 (de) * 2007-08-20 2011-06-16 Eberhard-Karls-Universität Tübingen Universitätsklinikum Kollagenhaltiger Zellträger
MX2010004838A (es) * 2007-10-30 2010-05-21 Baxter Int Uso de una biomatriz de colageno biofuncional regenerativa para tratar defectos viscerales o parietales.
RU2545810C2 (ru) 2008-02-29 2015-04-10 Ферросан Медикал Дивайсиз А/С Устройство для ускорения остановки кровотечения и/или заживления ран
US9039783B2 (en) 2009-05-18 2015-05-26 Baxter International, Inc. Method for the improvement of mesh implant biocompatibility
EP2442835B1 (en) * 2009-06-16 2014-12-10 Baxter International Inc Hemostatic sponge
WO2011079336A1 (en) * 2009-12-16 2011-07-07 Baxter International Inc. Hemostatic sponge
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
US8790699B2 (en) 2010-04-23 2014-07-29 Warsaw Orthpedic, Inc. Foam-formed collagen strand
US8460691B2 (en) 2010-04-23 2013-06-11 Warsaw Orthopedic, Inc. Fenestrated wound repair scaffold
KR101957625B1 (ko) 2010-06-01 2019-03-12 백스터 인터내셔널 인코포레이티드 건조 및 안정한 지혈 조성물의 제조 방법
CA2801116C (en) 2010-06-01 2019-02-12 Baxter International Inc. Process for making dry and stable hemostatic compositions
AU2011260274B2 (en) 2010-06-01 2015-07-02 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
KR102102002B1 (ko) 2011-10-11 2020-04-20 백스터 인터내셔널 인코포레이티드 지혈 조성물
ES2938566T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
US20130108671A1 (en) 2011-10-27 2013-05-02 Baxter Healthcare S.A. Hemostatic compositions
JP6241624B2 (ja) 2012-03-06 2017-12-06 フェロサン メディカル デバイシーズ エイ/エス 止血ペーストを収容する加圧容器
EP2825216B1 (en) 2012-06-12 2015-08-19 Ferrosan Medical Devices A/S Dry haemostatic composition
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー/エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
CN105828844B (zh) 2013-12-11 2019-09-27 弗罗桑医疗设备公司 包含挤出增强剂的干组合物
JP6726852B2 (ja) 2014-10-13 2020-07-22 フェッローサン メディカル ディバイス エー/エス 止血および創傷治癒に使用するための乾燥組成物
CA2970710A1 (en) 2014-12-24 2016-06-30 Ferrosan Medical Devices A/S Syringe for retaining and mixing first and second substances
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
WO2016149013A1 (en) * 2015-03-13 2016-09-22 Corning Incorporated Methods and systems for processing glass ribbons and glass ribbons formed thereby
EP3316930B1 (en) 2015-07-03 2019-07-31 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
US20210046163A1 (en) * 2019-08-12 2021-02-18 Bioregentech, Inc. Therapeutic systems, devices, and compositions with wound healing and tissue regenerative properties, uses thereof, and corresponding methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3800792A (en) * 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
DE2734503C2 (de) * 1977-07-30 1984-04-05 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
DE3020611C2 (de) * 1980-05-30 1983-01-05 Chemokol Gesellschaft zur Entwicklung von Kollagenprodukten, 5190 Stolberg Verfahren zur Herstellung von Kollagenmaterial für chirurgische Zwecke
DE3203957A1 (de) * 1982-02-05 1983-08-18 Chemokol Gesellschaft zur Entwicklung von Kollagenprodukten, 5190 Stolberg Verfahren zur herstellung von feinporigen kollagenschwaemmen
US4925924A (en) * 1984-03-27 1990-05-15 University Of Medicine And Dentistry Of New Jersey Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof
ATE109491T1 (de) * 1988-03-11 1994-08-15 Chemokol G B R Ing Buero Fuer Verfahren zur herstellung von kollagenmembranen für hämostase, wundbehandlung und implantate.
DE4028622C2 (de) * 1990-09-08 1994-01-27 Suwelack Nachf Dr Otto Verfahren zum Herstellen von Kollagenschwämmen

Also Published As

Publication number Publication date
JPH07501004A (ja) 1995-02-02
DE4227681C2 (de) 1995-05-18
DE4405130C2 (de) 1999-07-08
EP0612252B1 (de) 1999-05-12
US5520925A (en) 1996-05-28
US6022557A (en) 2000-02-08
WO1994004201A1 (de) 1994-03-03
DE4405130A1 (de) 1995-08-24
EP0612252A1 (de) 1994-08-31
DE4227681A1 (de) 1994-02-24
ATE179895T1 (de) 1999-05-15

Similar Documents

Publication Publication Date Title
ES2133407T3 (es) Material de recubrimiento de heridas fabricado a base de fibras de colageno.
MY110744A (en) Process for producing acetic acid
DE59811531D1 (de) Verfahren zur Herstellung von Polyisocyanaten
PT839196E (pt) Ctla-8 humana e utilizacoes de proteinas relacionadas com ctla-8
PT1165791E (pt) Citocina humana como ligando do receptor zalpha e seus usos
GR3015741T3 (en) Antifungal polypeptide, process for producing it.
DE69129119D1 (en) A process for the production of polyalkylenoxide
PL326271A1 (en) Novel thin catalysts, method of obtaining them and their application as well as crossklinkg compositions containing such novel thin catalysts
ES2092832T3 (es) Procedimiento para la modificacion de (co)polimeros de alfa-olefinas.
DE69432140D1 (de) Verfahren zur Herstellung von 9-Desoxotaxanen
DE69308143D1 (de) Verfahren zur herstellung von polymilchsäure
NO970902D0 (no) Ikke selvinaktiverende, målrettet retrovirak ekspresjonsvektorer
WO1991011462A3 (en) Merosin, nucleic acids encoding, fragments and uses thereof
ATE201882T1 (de) Formulierung von energie
CA2228939A1 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
ATE175693T1 (de) Herstellung von anhydropolyamidsäuren
HK1008225A1 (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
CA2140629A1 (fr) Solution de polyimide et leur procede d'obtention
ATE169027T1 (de) Herstellung von fluoro-nukleosiden und dafür geeignete zwischenprodukte
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
ATE244760T1 (de) Wachtumsfaktor aus der harp-reihe, verfahren zu ihrer herstellung und verwendungen davon
ATE192437T1 (de) Verfahren zur herstellung von 3-amino-2-chlor-4- alkyl- bzw. 4-cycloalkyl-pyridine
EP0863209A3 (en) Polyhydroxyalkanoate depolymerase and process for producing the same
EP0446361A4 (en) Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
DE59407666D1 (de) VERFAHREN ZUR HERSTELLUNG VON 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDAN

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 612252

Country of ref document: ES